share_log

Oppenheimer Upgrades Moderna to Outperform, Announces $142 Price Target

Oppenheimer Upgrades Moderna to Outperform, Announces $142 Price Target

奥本海默将Moderna上调至跑赢大盘,宣布目标股价142美元
Benzinga ·  01/02 07:43

Oppenheimer analyst Hartaj Singh upgrades Moderna (NASDAQ:MRNA) from Perform to Outperform and announces $142 price target.

奥本海默分析师哈塔杰·辛格将Moderna(纳斯达克股票代码:MRNA)从表现上调至跑赢大盘,并宣布目标股价为142美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发